TY  - ADVS
AU  - Reardon,David A.
TI  - Immune checkpoint blockade in CNS tumors
T2  - Immunotherapy of cancer,
PY  - 2016///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Brain
KW  - Cancer
KW  - Chemotherapy
KW  - Immunological aspects
KW  - Treatment
KW  - Central nervous system
KW  - Glioblastoma Multiforme
KW  - Immunotherapy
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - drug therapy
KW  - immunology
KW  - Central Nervous System Neoplasms
KW  - Glioblastoma
KW  - therapy
KW  - Immunologic Factors
KW  - pharmacology
KW  - Immunologic Memory
KW  - Immunosuppressive Agents
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Immunotherapy in oncology -- CNS immunoprivilege -- Glioblastoma (GBM): complexity/redundancy/heterogeneity -- "Established" and "Advanced" GBM models -- Tumor-specific immune response in GBM -- Importance of heterogeneity -- Overcoming challenges for durable GBM benefit -- Neoantigen mutations -- Checkpoint blockade & immunologic memory -- GBM vaccines -- Personalized neoantigen vaccine ("NeoVax") -- Immunotherapy response assessment in neuro-oncology (iRANO) -- Clinical trials in neuro-oncology -- Immunosuppressive mechanisms in GBM -- Combination anti-tumor immunotherapy; Access restricted to subscribers
UR  - https://hstalks.com/bs/3225/
UR  - https://hstalks.com/bs/p/896/
ER  -